The global Cell Isolation market is projected to generate a revenue of $34,746.3 million by 2030, advancing at a CAGR of 17.1% during 2022–2030. This will be due to rising demand for biopharmaceuticals, increasing government funding for cell-based research, and growing research regarding personalized medicine.
Increasing number of people in developed countries are opting for personalized medicine owing to increasing awareness, thus boosting the demand for the same. Moreover, reimbursement schemes in developed countries have led to an increase in demand for these medicines, as they can be afforded by most of the population. For instance, Medicare is the largest health insurance program in the U.S., which provides care for those aged 65 years and above, irrespective of their income and medical history. The rising adoption of next generation sequencing for genetic mapping of patients by medical practitioners has also increased the demand for personalized medicine.
Surface marker technique is expected to grow the fastest with a highest CAGR of over 20% during the forecast period. This technique has several advantages over centrifugation and filtration, such as non-dependence on density and size of cells, which will contribute to the increase in demand for surface marker technique-based cell isolation products.
Cell surface markers are put to use for the classification of cells based on their markers. This information is then utilized to identify various types of cells, ranging from cancer cells to stem cells to HIV-infected cells. All in all, cell surface markers are similar to fingerprints in a sense that they are unique to each type of cell and may be identified based on the types of markers present on the membrane. Apart from just the identification of cells, these also have the ability to aid in drug discovery and particularly personalized medicine. With the competence of identifying individual cells as per surface markers, scientists have started making breakthroughs in the new drug development process.
Moreover, cell isolation is used in cancer research, this is mainly due to the increasing prevalence of cancer. Incidence of cancer is rising due to an increase in various risk factors. These include the fact that, people are living longer lives and the risk of cancer increases with age as well as the fact that many individuals are obese contributing to increased risk of cancer. Cancer is the leading cause of mortality worldwide, accounting for over 10 million deaths in 2020, or over one in every six people.
APAC cell isolation market is projected to showcase highest growth during the forecast period, owing to high presence of clinical research organizations and biopharmaceutical companies in this region. Developing economies, presence of large biotechnology companies, and rise in the prevalence of chronic diseases are some of the other factors boosting the growth of the industry in the region.
Moreover, Japan contributes to the largest share in the APAC region, mainly due to advanced healthcare infrastructure, presence of large number of research institutions and government funding for basic and applied research, and availability of technologically advanced cell isolation products. The healthcare industry in the country is considerably developed with presence of advanced manufacturing facilities and technologies. Availability of advanced healthcare infrastructure, rising adoption of innovative cell isolation products, and increasing demand for regenerative medicines are expected to fuel the market growth.
Major players operating in the global cell isolation market are Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Danaher Corporation, Merck KGaA, Terumo Corporation, General Electric Company, Bio-Rad Laboratories Inc., Corning Incorporated, Alfa Laval AB, and Miltenyi Biotec.